Last 12 months
Inside the activity.
0 purchase rows · 49 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 10 |
| Jan 2026 | 0 | 4 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 12 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 08, 2025 Filed Sep 9, 2025 20:12 UTC |
Feider StephenChief Financial Officer
|
Exercise / conversionCommon Stock | 9,900 | $5.10 | $50,490.00 |
DisclosureSEC source: 0001415889-25-023969 · form4-09092025_080923.xml · nonDerivative · entry 1 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 05, 2025 Filed Sep 8, 2025 22:15 UTC |
Hopman MarkChief Commercial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 11,411 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001415889-25-023899 · form4-09082025_060903.xml · derivative · entry 8 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,725 Underlying: Common Stock · 11,411 shares Expires 2033-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023. Read SEC document |
| September 05, 2025 Filed Sep 8, 2025 22:15 UTC |
Hopman MarkChief Commercial Officer
|
SaleCommon Stock | 11,411 | $20.56 | $234,656.95 |
DisclosureSEC source: 0001415889-25-023899 · form4-09082025_060903.xml · nonDerivative · entry 5 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,215 F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025. F3 · price: The weighted average sale price for the transaction reported was $20.564162 and the range of prices were between $20.29 and $20.80. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| September 05, 2025 Filed Sep 8, 2025 22:15 UTC |
Hopman MarkChief Commercial Officer
|
Exercise / conversionCommon Stock | 11,411 | $5.10 | $58,196.10 |
DisclosureSEC source: 0001415889-25-023899 · form4-09082025_060903.xml · nonDerivative · entry 4 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,626 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 05, 2025 Filed Sep 8, 2025 22:15 UTC |
Feider StephenChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 100 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001415889-25-023898 · form4-09082025_060901.xml · derivative · entry 3 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 99,595 Underlying: Common Stock · 100 shares Expires 2033-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023. Read SEC document |
| September 05, 2025 Filed Sep 8, 2025 22:15 UTC |
Feider StephenChief Financial Officer
|
SaleCommon Stock | 100 | $21.00 | $2,100.00 |
DisclosureSEC source: 0001415889-25-023898 · form4-09082025_060901.xml · nonDerivative · entry 2 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,041 F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025. Read SEC document |
| September 05, 2025 Filed Sep 8, 2025 22:15 UTC |
Feider StephenChief Financial Officer
|
Exercise / conversionCommon Stock | 100 | $5.10 | $510.00 |
DisclosureSEC source: 0001415889-25-023898 · form4-09082025_060901.xml · nonDerivative · entry 1 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,141 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 22:15 UTC |
Hopman MarkChief Commercial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,093 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001415889-25-023899 · form4-09082025_060903.xml · derivative · entry 7 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,136 Underlying: Common Stock · 4,093 shares Expires 2033-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 22:15 UTC |
Hopman MarkChief Commercial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 656 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001415889-25-023899 · form4-09082025_060903.xml · derivative · entry 6 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,428 Underlying: Common Stock · 656 shares Expires 2033-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-fourth of the shares subject to this option shall vest one year after March 20, 2023, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 22:15 UTC |
Hopman MarkChief Commercial Officer
|
SaleCommon Stock | 6,818 | $19.97 | $136,180.00 |
DisclosureSEC source: 0001415889-25-023899 · form4-09082025_060903.xml · nonDerivative · entry 3 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,215 F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025. F2 · price: The weighted average sale price for the transaction reported was $19.9736 and the range of prices were between $19.43 and $20.10. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 22:15 UTC |
Hopman MarkChief Commercial Officer
|
Exercise / conversionCommon Stock | 4,093 | $5.10 | $20,874.30 |
DisclosureSEC source: 0001415889-25-023899 · form4-09082025_060903.xml · nonDerivative · entry 2 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,033 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 22:15 UTC |
Hopman MarkChief Commercial Officer
|
Exercise / conversionCommon Stock | 656 | $5.10 | $3,345.60 |
DisclosureSEC source: 0001415889-25-023899 · form4-09082025_060903.xml · nonDerivative · entry 1 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,940 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 22:45 UTC |
Russell Steven JonChief Medical Officer
|
SaleCommon Stock | 1,015 | $18.86 | $19,146.15 |
DisclosureSEC source: 0001415889-25-023745 · form4-09042025_060908.xml · nonDerivative · entry 1 Russell Steven Jon · CIK 0002051384 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,017 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. F2 · price: The weighted average sale price for the transaction reported was $18.8632 and the range of prices were between $18.58 and $19.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 22:45 UTC |
Mensinger MikeChief Product Officer
|
SaleCommon Stock | 1,089 | $18.86 | $20,542.02 |
DisclosureSEC source: 0001415889-25-023744 · form4-09042025_060906.xml · nonDerivative · entry 1 Mensinger Mike · CIK 0002048500 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,815 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. F2 · price: The weighted average sale price for the transaction reported was $18.8632 and the range of prices were between $18.58 and $19.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 22:45 UTC |
Saint SeanDirector · President & CEO
|
SaleCommon Stock | 3,359 | $18.86 | $63,361.49 |
DisclosureSEC source: 0001415889-25-023746 · form4-09042025_060910.xml · nonDerivative · entry 1 Saint Sean · CIK 0002048593 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,202 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. F2 · price: The weighted average sale price for the transaction reported was $18.8632 and the range of prices were between $18.58 and $19.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 22:45 UTC |
Hopman MarkChief Commercial Officer
|
SaleCommon Stock | 848 | $18.86 | $15,995.99 |
DisclosureSEC source: 0001415889-25-023743 · form4-09042025_060904.xml · nonDerivative · entry 1 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,284 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. F2 · price: The weighted average sale price for the transaction reported was $18.8632 and the range of prices were between $18.58 and $19.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 22:45 UTC |
Feider StephenChief Financial Officer
|
SaleCommon Stock | 1,462 | $18.86 | $27,578.00 |
DisclosureSEC source: 0001415889-25-023742 · form4-09042025_060901.xml · nonDerivative · entry 1 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,041 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. F2 · price: The weighted average sale price for the transaction reported was $18.8632 and the range of prices were between $18.58 and $19.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 22, 2025 Filed Aug 26, 2025 20:29 UTC |
Feider StephenChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,413 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001415889-25-023023 · form4-08262025_080841.xml · derivative · entry 3 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 99,695 Underlying: Common Stock · 4,413 shares Expires 2033-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023. Read SEC document |
| August 22, 2025 Filed Aug 26, 2025 20:29 UTC |
Feider StephenChief Financial Officer
|
SaleCommon Stock | 4,413 | $17.01 | $75,082.78 |
DisclosureSEC source: 0001415889-25-023023 · form4-08262025_080841.xml · nonDerivative · entry 2 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,503 F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025. F2 · price: The weighted average sale price for the transaction reported was $17.0140 and the range of prices were between $17.00 and $17.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 22, 2025 Filed Aug 26, 2025 20:29 UTC |
Feider StephenChief Financial Officer
|
Exercise / conversionCommon Stock | 4,413 | $5.10 | $22,506.30 |
DisclosureSEC source: 0001415889-25-023023 · form4-08262025_080841.xml · nonDerivative · entry 1 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,916 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 01:30 UTC |
Hopman MarkChief Commercial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 16,158 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001415889-25-022540 · form4-08202025_090803.xml · derivative · entry 3 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,084 Underlying: Common Stock · 16,158 shares Expires 2033-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One-fourth of the shares subject to this option shall vest one year after March 20, 2023, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof. Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 01:30 UTC |
Hopman MarkChief Commercial Officer
|
SaleCommon Stock | 16,158 | $16.61 | $268,376.30 |
DisclosureSEC source: 0001415889-25-022540 · form4-08202025_090803.xml · nonDerivative · entry 2 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,132 F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025. F2 · price: The weighted average sale price for the transaction reported was $16.6095 and the range of prices were between $16.26 and $17.1719. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 01:30 UTC |
Hopman MarkChief Commercial Officer
|
Exercise / conversionCommon Stock | 16,158 | $5.10 | $82,405.80 |
DisclosureSEC source: 0001415889-25-022540 · form4-08202025_090803.xml · nonDerivative · entry 1 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 01:30 UTC |
Feider StephenChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,587 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001415889-25-022539 · form4-08202025_090801.xml · derivative · entry 3 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,108 Underlying: Common Stock · 5,587 shares Expires 2033-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023. Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 01:30 UTC |
Feider StephenChief Financial Officer
|
SaleCommon Stock | 5,587 | $17.03 | $95,171.75 |
DisclosureSEC source: 0001415889-25-022539 · form4-08202025_090801.xml · nonDerivative · entry 2 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,503 F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025. F2 · price: The weighted average sale price for the transaction reported was $17.034505 and the range of prices were between $17.00 and $17.095. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 01:30 UTC |
Feider StephenChief Financial Officer
|
Exercise / conversionCommon Stock | 5,587 | $5.10 | $28,493.70 |
DisclosureSEC source: 0001415889-25-022539 · form4-08202025_090801.xml · nonDerivative · entry 1 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,090 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 23:30 UTC |
Russell Steven JonChief Medical Officer
|
SaleCommon Stock | 94 | $18.69 | $1,756.95 |
DisclosureSEC source: 0001415889-25-015669 · form4-06042025_070614.xml · nonDerivative · entry 3 Russell Steven Jon · CIK 0002051384 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,032 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. F4 · price: The weighted average sale price for the transaction reported was $18.691 and the range of prices were between $18.69 and $18.73. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 23:30 UTC |
Russell Steven JonChief Medical Officer
|
SaleCommon Stock | 660 | $18.15 | $11,978.27 |
DisclosureSEC source: 0001415889-25-015669 · form4-06042025_070614.xml · nonDerivative · entry 2 Russell Steven Jon · CIK 0002051384 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,126 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. F3 · price: The weighted average sale price for the transaction reported was $18.1489 and the range of prices were between $17.62 and $18.60. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 23:30 UTC |
Russell Steven JonChief Medical Officer
|
SaleCommon Stock | 285 | $17.03 | $4,852.98 |
DisclosureSEC source: 0001415889-25-015669 · form4-06042025_070614.xml · nonDerivative · entry 1 Russell Steven Jon · CIK 0002051384 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,786 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. F2 · price: The weighted average sale price for the transaction reported was $17.028 and the range of prices were between $16.62 and $17.56. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 23:30 UTC |
Hopman MarkChief Commercial Officer
|
SaleCommon Stock | 79 | $18.69 | $1,476.59 |
DisclosureSEC source: 0001415889-25-015670 · form4-06042025_070616.xml · nonDerivative · entry 3 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,132 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. F4 · price: The weighted average sale price for the transaction reported was $18.691 and the range of prices were between $18.69 and $18.73. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 23:30 UTC |
Hopman MarkChief Commercial Officer
|
SaleCommon Stock | 551 | $18.15 | $10,000.04 |
DisclosureSEC source: 0001415889-25-015670 · form4-06042025_070616.xml · nonDerivative · entry 2 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,211 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. F3 · price: The weighted average sale price for the transaction reported was $18.1489 and the range of prices were between $17.62 and $18.60. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 23:30 UTC |
Hopman MarkChief Commercial Officer
|
SaleCommon Stock | 238 | $17.03 | $4,052.66 |
DisclosureSEC source: 0001415889-25-015670 · form4-06042025_070616.xml · nonDerivative · entry 1 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,762 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. F2 · price: The weighted average sale price for the transaction reported was $17.028 and the range of prices were between $16.62 and $17.56. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 23:30 UTC |
Mensinger MikeChief Product Officer
|
SaleCommon Stock | 101 | $18.69 | $1,887.79 |
DisclosureSEC source: 0001415889-25-015668 · form4-06042025_070612.xml · nonDerivative · entry 3 Mensinger Mike · CIK 0002048500 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,904 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. F4 · price: The weighted average sale price for the transaction reported was $18.691 and the range of prices were between $18.69 and $18.73. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 23:30 UTC |
Mensinger MikeChief Product Officer
|
SaleCommon Stock | 708 | $18.15 | $12,849.42 |
DisclosureSEC source: 0001415889-25-015668 · form4-06042025_070612.xml · nonDerivative · entry 2 Mensinger Mike · CIK 0002048500 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,005 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. F3 · price: The weighted average sale price for the transaction reported was $18.1489 and the range of prices were between $17.62 and $18.60. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 23:30 UTC |
Mensinger MikeChief Product Officer
|
SaleCommon Stock | 306 | $17.03 | $5,210.57 |
DisclosureSEC source: 0001415889-25-015668 · form4-06042025_070612.xml · nonDerivative · entry 1 Mensinger Mike · CIK 0002048500 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,713 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. F2 · price: The weighted average sale price for the transaction reported was $17.028 and the range of prices were between $16.62 and $17.56. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 23:30 UTC |
Saint SeanDirector · President & CEO
|
SaleCommon Stock | 311 | $18.69 | $5,812.90 |
DisclosureSEC source: 0001415889-25-015666 · form4-06042025_070601.xml · nonDerivative · entry 3 Saint Sean · CIK 0002048593 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,561 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. F4 · price: The weighted average sale price for the transaction reported was $18.691 and the range of prices were between $18.69 and $18.73. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 23:30 UTC |
Saint SeanDirector · President & CEO
|
SaleCommon Stock | 2,185 | $18.15 | $39,655.35 |
DisclosureSEC source: 0001415889-25-015666 · form4-06042025_070601.xml · nonDerivative · entry 2 Saint Sean · CIK 0002048593 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,872 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. F3 · price: The weighted average sale price for the transaction reported was $18.1489 and the range of prices were between $17.62 and $18.60. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 23:30 UTC |
Saint SeanDirector · President & CEO
|
SaleCommon Stock | 943 | $17.03 | $16,057.40 |
DisclosureSEC source: 0001415889-25-015666 · form4-06042025_070601.xml · nonDerivative · entry 1 Saint Sean · CIK 0002048593 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,057 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. F2 · price: The weighted average sale price for the transaction reported was $17.028 and the range of prices were between $16.62 and $17.56. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 23:30 UTC |
Feider StephenChief Financial Officer
|
SaleCommon Stock | 136 | $18.69 | $2,541.98 |
DisclosureSEC source: 0001415889-25-015667 · form4-06042025_070608.xml · nonDerivative · entry 3 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,503 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. F4 · price: The weighted average sale price for the transaction reported was $18.691 and the range of prices were between $18.69 and $18.73. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 23:30 UTC |
Feider StephenChief Financial Officer
|
SaleCommon Stock | 951 | $18.15 | $17,259.60 |
DisclosureSEC source: 0001415889-25-015667 · form4-06042025_070608.xml · nonDerivative · entry 2 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,639 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. F3 · price: The weighted average sale price for the transaction reported was $18.1489 and the range of prices were between $17.62 and $18.60. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 23:30 UTC |
Feider StephenChief Financial Officer
|
SaleCommon Stock | 410 | $17.03 | $6,981.48 |
DisclosureSEC source: 0001415889-25-015667 · form4-06042025_070608.xml · nonDerivative · entry 1 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,590 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. F2 · price: The weighted average sale price for the transaction reported was $17.028 and the range of prices were between $16.62 and $17.56. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| March 26, 2025 Filed Mar 27, 2025 23:04 UTC |
MICHEL GERARD JDirector
|
GrantCommon Stock | 12,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-009123 · form4-03272025_110352.xml · nonDerivative · entry 1 MICHEL GERARD J · CIK 0001235644 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,547 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| March 15, 2025 Filed Mar 19, 2025 00:00 UTC |
Palasis MariaDirector
|
GrantCommon Stock | 11,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008536 · form4-03182025_080308.xml · nonDerivative · entry 1 Palasis Maria · CIK 0001810701 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,247 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| March 15, 2025 Filed Mar 19, 2025 00:00 UTC |
Jones ChristyDirector
|
GrantCommon Stock | 11,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008537 · form4-03182025_080310.xml · nonDerivative · entry 1 Jones Christy · CIK 0002048467 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,247 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| March 15, 2025 Filed Mar 19, 2025 00:00 UTC |
Dearen Danny L.Director
|
GrantCommon Stock | 11,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008535 · form4-03182025_080306.xml · nonDerivative · entry 1 Dearen Danny L. · CIK 0001756438 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,247 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| March 15, 2025 Filed Mar 19, 2025 00:00 UTC |
Lezack AdamDirector
|
GrantCommon Stock | 11,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008534 · form4-03182025_080304.xml · nonDerivative · entry 1 Lezack Adam · CIK 0002048466 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,247 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| March 15, 2025 Filed Mar 19, 2025 00:00 UTC |
CARNEY SEANDirector
|
GrantCommon Stock | 11,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008533 · form4-03182025_080301.xml · nonDerivative · entry 1 CARNEY SEAN · CIK 0001239312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,247 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 22:45 UTC |
Russell Steven JonChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 52,000 | $0.00 Strike: $19.91 | $0.00 |
DisclosureSEC source: 0001415889-25-006233 · form4-03032025_050309.xml · derivative · entry 2 Russell Steven Jon · CIK 0002051384 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,000 Underlying: Common Stock · 52,000 shares Expires 2035-02-26 F2 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from February 27, 2025. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 22:45 UTC |
Russell Steven JonChief Medical Officer
|
GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-006233 · form4-03032025_050309.xml · nonDerivative · entry 1 Russell Steven Jon · CIK 0002051384 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,071 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 22:45 UTC |
Hopman MarkChief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 52,000 | $0.00 Strike: $19.91 | $0.00 |
DisclosureSEC source: 0001415889-25-006234 · form4-03032025_050311.xml · derivative · entry 2 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,000 Underlying: Common Stock · 52,000 shares Expires 2035-02-26 F2 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from February 27, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.